{"created":"2023-06-20T16:00:25.687375+00:00","id":18842,"links":{},"metadata":{"_buckets":{"deposit":"17f6b286-7862-4319-bfa6-067f7a89ff99"},"_deposit":{"created_by":41,"id":"18842","owners":[41],"pid":{"revision_id":0,"type":"depid","value":"18842"},"status":"published"},"_oai":{"id":"oai:redcross.repo.nii.ac.jp:00018842","sets":["340:341:733"]},"author_link":["70597","70593","70595","70591","70598","70594","70592","70596"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2023-03-31","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"4","bibliographicPageStart":"1","bibliographicVolumeNumber":"27","bibliographic_titles":[{"bibliographic_title":"高知赤十字病院医学雑誌"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"放射性塩化ラジウム（223Ra）は，骨転移を有する去勢抵抗性前立腺癌の，骨関連事象発現までの期間，全生存期間を延長させることができる．しかし，そのほかにも複数の薬剤が承認されており，現時点でこれらの投与順序や，適正な投与時期，評価方法などの明確な指標がない．一方，223Ra は 5 回あるいは 6 回完遂した症例が，より予後が長いことが分かってきている．今回，当院で経験した 25 症例を対象に，完遂できる因子があるかどうか検討した．治療前に適切な指標となるバイオマーカーなどは見つからなかったが，投与開始後の LDH の推移が完遂因子であることが示唆された．今後の症例の蓄積とデータの収集が待たれる．","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"高知赤十字病院"}]},"item_10001_rights_15":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"高知赤十字病院"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0919-7427","subitem_source_identifier_type":"ISSN"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"中谷, 貴美子"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"伊藤, 悟志"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"森, 亮輔"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"太田, 裕司"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"高橋, 健次郎"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"山本, 晃司"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"奈路田, 拓史"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"田村, 雅人"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-06-02"}],"displaytype":"simple","filename":"放射線科 中谷貴美子.pdf","filesize":[{"value":"302.1 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"高知赤十字病院医学雑誌Vol.27-01","url":"https://redcross.repo.nii.ac.jp/record/18842/files/放射線科 中谷貴美子.pdf"},"version_id":"1be5f4bc-1503-402a-8019-9db1c8325ce2"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"去勢抵抗性前立腺癌","subitem_subject_scheme":"Other"},{"subitem_subject":"CRPC","subitem_subject_scheme":"Other"},{"subitem_subject":"骨転移","subitem_subject_scheme":"Other"},{"subitem_subject":"放射性塩化ラジウム223Ra","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"骨転移を有する去勢抵抗性前立腺癌に対する 223Ra の完遂条件に関する検討","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"骨転移を有する去勢抵抗性前立腺癌に対する 223Ra の完遂条件に関する検討"}]},"item_type_id":"10001","owner":"41","path":["733"],"pubdate":{"attribute_name":"公開日","attribute_value":"2023-06-02"},"publish_date":"2023-06-02","publish_status":"0","recid":"18842","relation_version_is_last":true,"title":["骨転移を有する去勢抵抗性前立腺癌に対する 223Ra の完遂条件に関する検討"],"weko_creator_id":"41","weko_shared_id":-1},"updated":"2023-06-20T17:34:43.373914+00:00"}